• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-(4-取代苯甲酰基)-N'-(β-D-吡喃葡萄糖基)脲作为糖原磷酸化酶抑制剂的研究:通过动力学、晶体学和分子模拟方法的合成与评价。

N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.

机构信息

Department of Organic Chemistry, University of Debrecen, Debrecen, Hungary.

出版信息

Bioorg Med Chem. 2012 Mar 1;20(5):1801-16. doi: 10.1016/j.bmc.2011.12.059. Epub 2012 Jan 20.

DOI:10.1016/j.bmc.2011.12.059
PMID:22325154
Abstract

N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl) ureas (substituents: Me, Ph, Cl, OH, OMe, NO(2), NH(2), COOH, and COOMe) were synthesised by ZnCl(2) catalysed acylation of O-peracetylated β-d-glucopyranosyl urea as well as in reactions of O-peracetylated or O-unprotected glucopyranosylamines and acyl-isocyanates. O-deprotections were carried out by base or acid catalysed transesterifications where necessary. Kinetic studies revealed that most of these compounds were low micromolar inhibitors of rabbit muscle glycogen phosphorylase b (RMGPb). The best inhibitor was the 4-methylbenzoyl compound (K(i)=2.3μM). Crystallographic analyses of complexes of several of the compounds with RMGPb showed that the analogues exploited, together with water molecules, the available space at the β-pocket subsite and induced a more extended shift of the 280s loop compared to RMGPb in complex with the unsubstituted benzoyl urea. The results suggest the key role of the water molecules in ligand binding and structure-based ligand design. Molecular docking study of selected inhibitors was done to show the ability of the binding affinity prediction. The binding affinity of the highest scored docked poses was calculated and correlated with experimentally measured K(i) values. Results show that correlation is high with the R-squared (R(2)) coefficient over 0.9.

摘要

N-(4-取代苯甲酰基)-N'-(β-D-吡喃葡萄糖基)脲(取代基:Me、Ph、Cl、OH、OMe、NO2、NH2、COOH 和 COOMe)通过 ZnCl2 催化的 O-乙酰化β-D-吡喃葡萄糖基脲的酰化反应以及 O-乙酰化或 O-未保护的吡喃葡萄糖胺和酰基异氰酸酯的反应合成。必要时通过碱或酸催化的酯交换进行 O-脱保护。动力学研究表明,这些化合物大多数是兔肌肉糖原磷酸化酶 b(RMGPb)的低微摩尔抑制剂。最好的抑制剂是 4-甲基苯甲酰化合物(K(i)=2.3μM)。几种化合物与 RMGPb 的复合物的晶体学分析表明,这些类似物与水分子一起利用了β-口袋亚基的可用空间,并与未取代的苯甲酰脲与 RMGPb 形成的复合物相比,诱导 280s 环更伸展的移动。结果表明,水分子在配体结合和基于结构的配体设计中起着关键作用。对选定抑制剂进行了分子对接研究,以展示结合亲和力预测的能力。计算了最高得分对接构象的结合亲和力,并与实验测量的 K(i)值相关联。结果表明,相关性很高,R-平方(R(2))系数超过 0.9。

相似文献

1
N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.N-(4-取代苯甲酰基)-N'-(β-D-吡喃葡萄糖基)脲作为糖原磷酸化酶抑制剂的研究:通过动力学、晶体学和分子模拟方法的合成与评价。
Bioorg Med Chem. 2012 Mar 1;20(5):1801-16. doi: 10.1016/j.bmc.2011.12.059. Epub 2012 Jan 20.
2
Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.糖原磷酸化酶抑制剂4-苯基-N-(β-D-吡喃葡萄糖基)-1H-1,2,3-三唑-1-乙酰胺的晶体学和计算研究:与α-D-葡萄糖、N-乙酰-β-D-吡喃葡萄糖胺和N-苯甲酰基-N'-β-D-吡喃葡萄糖基脲结合的比较
Proteins. 2008 May 15;71(3):1307-23. doi: 10.1002/prot.21837.
3
Assessment of synthetic methods for the preparation of N-beta-d-glucopyranosyl-N'-substituted ureas, -thioureas and related compounds.N-β-D-吡喃葡萄糖基-N'-取代脲、硫脲及相关化合物合成方法的评估
Carbohydr Res. 2008 Aug 11;343(12):2083-93. doi: 10.1016/j.carres.2008.01.045. Epub 2008 Feb 7.
4
Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.吡喃葡萄糖亚基-螺-亚氨基噻唑烷酮,一种新型双环体系:通过酶动力学和晶体学方法进行合成、衍生化及糖原磷酸化酶抑制作用评估
Bioorg Med Chem. 2014 Aug 1;22(15):4028-41. doi: 10.1016/j.bmc.2014.05.076. Epub 2014 Jun 16.
5
New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.3-(β-D-葡萄糖吡喃基)-5-取代-1,2,4-三唑的新合成,糖原磷酸化酶的纳摩尔级抑制剂。
Eur J Med Chem. 2014 Apr 9;76:567-79. doi: 10.1016/j.ejmech.2014.02.041. Epub 2014 Feb 15.
6
The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.β-D-葡萄糖基硫代氨基甲脒衍生物与糖原磷酸化酶的结合:一类新型抑制剂。
Bioorg Med Chem. 2010 Nov 15;18(22):7911-22. doi: 10.1016/j.bmc.2010.09.039. Epub 2010 Sep 22.
7
Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.C-β-d-吡喃葡萄糖基吡咯和咪唑的合成、酶动力学和蛋白质晶体学研究揭示并解释了其对人肝糖原磷酸化酶的低纳摩尔抑制作用。
Eur J Med Chem. 2016 Nov 10;123:737-745. doi: 10.1016/j.ejmech.2016.06.049. Epub 2016 Jul 12.
8
1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.1-(3-脱氧-3-氟-β-D-吡喃葡萄糖基)嘧啶衍生物作为糖原磷酸化酶 b 的抑制剂:动力学、晶体学和建模研究。
Bioorg Med Chem. 2010 May 15;18(10):3413-25. doi: 10.1016/j.bmc.2010.04.004. Epub 2010 Apr 7.
9
Synthesis of new glycosyl biuret and urea derivatives as potential glycoenzyme inhibitors.合成新型糖基缩二脲和脲衍生物作为潜在的糖苷酶抑制剂。
Carbohydr Res. 2010 Jan 26;345(2):208-13. doi: 10.1016/j.carres.2009.10.016. Epub 2009 Nov 10.
10
A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.3-(β-D-吡喃葡萄糖基)-5-取代-1,2,4-三唑衍生物作为糖原磷酸化酶抑制剂的多学科研究:计算、合成、晶体学和动力学揭示了新型强效抑制剂
Eur J Med Chem. 2018 Mar 10;147:266-278. doi: 10.1016/j.ejmech.2018.01.095. Epub 2018 Feb 2.

引用本文的文献

1
In the Search of Glycoside-Based Molecules as Antidiabetic Agents.寻找基于糖苷的分子作为抗糖尿病药物。
Top Curr Chem (Cham). 2019 Jun 5;377(4):19. doi: 10.1007/s41061-019-0243-6.
2
Glycogen phosphorylase inhibitor N-(3,5-dimethyl-Benzoyl)-N'-(β-D-glucopyranosyl)urea improves glucose tolerance under normoglycemic and diabetic conditions and rearranges hepatic metabolism.糖原磷酸化酶抑制剂 N-(3,5-二甲基苯甲酰基)-N'-(β-D-吡喃葡萄糖基)脲在正常血糖和糖尿病条件下改善葡萄糖耐量,并重新排列肝脏代谢。
PLoS One. 2013 Jul 25;8(7):e69420. doi: 10.1371/journal.pone.0069420. Print 2013.